ANVS
Annovis Bio Inc
1.40$
+5.3%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2011 | 2012 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | 100.0% | – | – | – | – | – | – | – | – | – | |
| 84.2% | – | 6.2% | – | – | – | – | – | – | – | – | – | |
| 15.8% | – | 93.8% | – | – | – | – | – | – | – | – | – | |
| 33.8% | – | 1,051.9% | – | – | – | – | – | – | – | – | – | |
| 118.0% | – | 1,058.1% | – | – | – | – | – | – | – | – | – | |
| -18.0% | – | -958.1% | – | – | – | – | – | – | – | – | – | |
| 0.0% | – | 0.0% | – | – | – | – | – | – | – | – | – | |
| -17.5% | – | -914.8% | – | – | – | – | – | – | – | – | – | |
| 0.8% | – | 0.0% | – | – | – | – | – | – | – | – | – | |
| -18.3% | – | -4,495.6% | – | – | – | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.